Finance

Lists
Why is HURA down 4.14%?
Dive Deeper
HURA:NASDAQ
TuHURA Biosciences Inc
$1.39
-4.14%
(-0.060) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HURA...
Open
$1.51
High
$1.53
Low
$1.36
Mkt. cap
88.58M
Avg. vol.
410.38K
Volume
371.86K
52-wk high
$3.43
52-wk low
$0.41
EPS
-$0.54
Beta
-0.23
Shares outstanding
63.73M
No. of employees
22
Open
$1.51
High
$1.53
Low
$1.36
Mkt. cap
88.58M
Avg. vol.
410.38K
Volume
371.86K
52-wk high
$3.43
52-wk low
$0.41
EPS
-$0.54
Beta
-0.23
Shares outstanding
63.73M
No. of employees
22
News stories
From web sources and news partners
About TuHURA Biosciences Inc
CEO-
Employees22
Founded1995
HeadquartersTampa, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitetuhurabio.com
Analyst ratings
Based on 2 analysts giving stock ratings to HURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for HURA in the last 3 months.
Highest
Current $1.39
$10.00 (+619.42%)
Average
$9.00 (+547.48%)
Lowest
$8.00 (+475.54%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
$10.00
+619.4%
10/27/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$8.00
+475.5%
08/25/2026
Silvan Turkcan
Citizens JMP
Buy
Initiated
$9.00
+547.5%
04/27/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
$9.00
+547.5%
04/27/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$7.00
+403.6%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.97M
6.06M
5.23M
6.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.76M
2.34M
2.30M
2.14M
Operating expense
6.73M
8.39M
7.53M
8.76M
Total operating expenses
6.73M
8.39M
7.53M
8.76M
Operating income
-6.73M
-8.39M
-7.53M
-8.76M
Other non operating income
-46.72K
185.02K
-
-
EBT including unusual items
-7.10M
-6.76M
-7.54M
-9.22M
EBT excluding unusual items
-6.79M
-8.82M
-7.54M
-9.22M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.10M
-6.76M
-7.54M
-9.22M
Net profit margin
-
-
-
-
Earnings per share
-0.14
-0.16
-0.13
-
Interest and investment income
6.06K
609.00
21.28K
7.62K
Interest expense
-16.53K
-608.75K
-27.97K
-467.63K
Net interest expenses
-10.47K
-608.14K
-6.70K
-460.01K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.71M
-8.37M
-7.51M
-8.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps